From the 1970s, serum tumor markers, such as beta human chorionic gonadotropin (bHCG), alpha fetoprotein (AFP), and lactate dehydrogenase (LDH), have been implemented in the routine clinical management of testicular cancer (TC) [2]. The gene discussed is AFP; the disease is neoplasm.